Tri-Institutional Therapeutics Discovery Institute

United States of America (USA)

1 March 2018 - 28 February 2019

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Tri-Institutional Therapeutics Discovery Institute published between 1 March 2018 - 28 February 2019 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Tri-Institutional Therapeutics Discovery Institute is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

AC FC
1 0.24

Outputs by subject (FC)

Subject AC FC
Life Sciences 1 0.24

Top articles by Altmetric score in current window

Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance.

Proceedings of the National Academy of Sciences of the United States of America

2018-07-02

1 March 2018 - 28 February 2019

International vs. domestic collaboration by FC

  • 75% Domestic
  • 25% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 international collaborators by FC (2 total)

  • Tri-Institutional Therapeutics Discovery Institute, United States of America (USA)
  • Foreign institution
  1. GlaxoSmithKline plc. (GSK), United Kingdom (UK) (0.29)
    0.24
    0.06
  2. Infectious Diseases Research Collaboration (IDRC), Uganda (0.26)
    0.24
    0.03

Note: Collaboration is determined by the fractional count (FC), which is listed in parentheses.

Participating institutions

Tri-Institutional Therapeutics Discovery Institute is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Return to institution outputs